Facilitated By

San Antonio Medical Foundation

Research Project Qualification Form

651 Results Page 31 of 66

A Multinational, Multicenter, Randomized, Phase 3 Study Of Tesetaxel Plus A Reduced Dose Of Capecitabine Versus Capecitabine Alone In Patients With HER2 Negative, Hormone Receptor Positive, Locally Advanced Or Metastatic Breast Cancer Previously Treated With A Taxane

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
HJF

This is a multinational, multicenter, randomized, open-label, parallel-group Phase 3 study. The primary objective is to compare the efficacy of tesetaxel plus a reduced dose of capecitabine versus the approved dose of capecitabine alone based on progression-free survival (PFS), as assessed by an Independent Radiologic Review Committee (IRC), in patients with HER2 negative, HR positive MBC previously treated with a taxane in the neoadjuvant or adjuvant setting.

Collaborative Project
Active Project
Cancer
Clinical Care

Rabies Virus-Mimetic Carriers for Brain Tumor Gene Therapy

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Romero Uribe, Gabriela
Funded by
San Antonio Area Fdn

Applied Research

Collaborative Project
Active Project
Cancer
Basic Research

A Phase 2B Randomized Study To Assess The Efficacy And Safety Of The Combination Of Ublituximab + TGR-1202 With Or Without Bendamustine And TGR-1202 Alone In Patients With Previously Treated Non-Hodgkins Lymphoma

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

This study is designed as a Phase 2b, randomized trial to evaluate the efficacy and safety of TGR-1202 alone and in combination with ublituximab with or without bendamustine in previously treated indolent non-Hodgkins lympoma (iNHL) and Diffuse Large B-Cell Lymphoma (DLBCL) patients. Following screening, qualified patients with Follicular Lymphoma ( FL) or Small Lymphocytic Lymphoma (SLL) will be randomized in a 1:1 ratio to one of two arms: Arm A: Ublituximab + TGR-1202, Arm B: TGR-1202.

Collaborative Project
Active Project
Cancer
Clinical Care

Single-Particle Characterization of Nanoparticle Bioconjugates

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Mayer, Kathryn
Funded by
Natl Inst of Health

Basic Research

Collaborative Project
Active Project
Aging
Behavioral Health
Cardiovascular
Infectious Disease
Diabetes and Obesity
Regenerative Medicine
Neuroscience
Musculoskeletal
Trauma
Cancer
Basic Research

PREDICTIVE NUMERICAL MODEL FOR OPTIMAL DELIVERY OF OXYGEN IN A NOVEL CELL EXPANSION BIOREACTOR

Southwest Research Institute

Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.

Principal Investigator(s)
Dr. Jian Ling
Kreg A. Zimmern
Funded by
Internally Funded

BACKGROUND

Collaborative Project
Active Project
Infectious Disease
Diabetes and Obesity
Regenerative Medicine
Trauma
Cancer
Biomechanics
Disease Modeling
Drug Discovery
Medical Devices

Unlocking museum collections for phylogenomic studies: a case study in lorisiform primates.

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Pozzi, Luca
Funded by
UTSA VPR Office

Basic Research

Collaborative Project
Active Project
Aging
Behavioral Health
Cardiovascular
Infectious Disease
Diabetes and Obesity
Regenerative Medicine
Neuroscience
Musculoskeletal
Trauma
Cancer
Basic Research
Genetics

Design and Synthesis of Small Molecule Inhibitors of Ebola

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
McHardy, Stanton
Funded by
Texas Biomedical Research Institute

Basic Research

Collaborative Project
Active Project
Aging
Behavioral Health
Cardiovascular
Infectious Disease
Diabetes and Obesity
Regenerative Medicine
Neuroscience
Musculoskeletal
Trauma
Cancer
Basic Research

Photosensitization of albumin: a potential approach to modulate drug delivery into abnormal cells

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Brancaleon, Lorenzo
Funded by
Natl Inst of Health

Basic Research

Collaborative Project
Active Project
Cancer
Basic Research

Collaboration for the Biomedical Applications of Protein Photosensitization.

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Brancaleon, Lorenzo
Funded by
Burroughs Wellcome Fund

Basic Research

Collaborative Project
Active Project
Aging
Behavioral Health
Cardiovascular
Infectious Disease
Diabetes and Obesity
Regenerative Medicine
Neuroscience
Musculoskeletal
Trauma
Cancer
Basic Research

Ultra Low Power Computing for Next Generation Implantable Smart Cardiac Pacemakers

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
John, Eugene
Funded by
Natl Inst of Health

Basic Research

Collaborative Project
Active Project
Aging
Behavioral Health
Cardiovascular
Infectious Disease
Diabetes and Obesity
Regenerative Medicine
Neuroscience
Musculoskeletal
Trauma
Cancer
Basic Research
Medical Devices